Growth, Therapeutic Effectiveness, and Disparities in Pediatric Type 1 Diabetes: Lessons from Continuous Glucose Monitoring Use in Latin America by Linda A. DiMeglio, MD, MPH, Adda Grimberg, MD

Get full text

57437 Effects of Prebiotics on the Gut Microbiome Profile, Beta-cell Function and Immune Markers in Newly-Diagnosed Type 1 Diabetes by Heba M. Ismail, Carmella Evans-Molina, Linda A. DiMeglio

Get full text

Evaluating the effect of prebiotics on the gut microbiome profile and β cell function in youth with newly diagnosed type 1 diabetes: protocol of a pilot randomized controlled trial... by Heba M. Ismail, Maria Spall, Carmella Evans-Molina, Linda A. DiMeglio

Get full text

Growth differentiation factor 15 (GDF15) elevation in children with newly diagnosed cancer by Daniel V. Runco, Daniel V. Runco, Daniel V. Runco, Linda A. DiMeglio, Linda A. DiMeglio, Charles P. Vanderpool, Charles P. Vanderpool, Yan Han, Joanne Daggy, Mary M. Kelley, Mary M. Kelley, Raya Mikesell, Raya Mikesell, Teresa A. Zimmers, Teresa A. Zimmers, Teresa A. Zimmers, Teresa A. Zimmers

Get full text

Safety and prescribing recommendations for verapamil in newly diagnosed pediatric type 1 diabetes (T1D): The CLVer experience by Laya Ekhlaspour, Bruce Buckingham, Colleen Bauza, Mark Clements, Gregory P. Forlenza, Anna Neyman, Lisa Norlander, Marcus Schamberger, Jennifer L. Sherr, Ryan Bailey, Roy W. Beck, Craig Kollman, Shannon Beasley, Erin Cobry, Linda A. DiMeglio, Emily Paprocki, Michelle Van Name, Antoinette Moran

Get full text

Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review by Jamie L. Felton, Kurt J. Griffin, Richard A. Oram, Cate Speake, S. Alice Long, Suna Onengut-Gumuscu, Stephen S. Rich, Gabriela S. F. Monaco, Carmella Evans-Molina, Linda A. DiMeglio, Heba M. Ismail, Andrea K. Steck, Dana Dabelea, Randi K. Johnson, Marzhan Urazbayeva, Stephen Gitelman, John M. Wentworth, Maria J. Redondo, Emily K. Sims, ADA/EASD PMDI

Get full text

Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review by Jamie L. Felton, Maria J. Redondo, Richard A. Oram, Cate Speake, S. Alice Long, Suna Onengut-Gumuscu, Stephen S. Rich, Gabriela S. F. Monaco, Arianna Harris-Kawano, Dianna Perez, Zeb Saeed, Benjamin Hoag, Rashmi Jain, Carmella Evans-Molina, Linda A. DiMeglio, Heba M. Ismail, Dana Dabelea, Randi K. Johnson, Marzhan Urazbayeva, John M. Wentworth, Kurt J. Griffin, Emily K. Sims, On behalf of the ADA/EASD PMDI

Get full text

IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes by Carla J. Greenbaum, Elisavet Serti, Katharina Lambert, Lia J. Weiner, Sai Kanaparthi, Sandra Lord, Stephen E. Gitelman, Darrell M. Wilson, Jason L. Gaglia, Kurt J. Griffin, William E. Russell, Philip Raskin, Antoinette Moran, Steven M. Willi, Eva Tsalikian, Linda A. DiMeglio, Kevan C. Herold, Wayne V. Moore, Robin Goland, Mark Harris, Maria E. Craig, Desmond A. Schatz, David A. Baidal, Henry Rodriguez, Kristina M. Utzschneider, Hendrik J. Nel, Carol L. Soppe, Karen D. Boyle, Karen Cerosaletti, Lynette Keyes-Elstein, S. Alice Long, Ranjeny Thomas, James G. McNamara, Jane H. Buckner, Srinath Sanda, for the ITN058AI EXTEND Study Team

Get full text